Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This source reports that clinical trials found oral baricitinib significantly improved hair regrowth in patients with severe alopecia areata, with 38.8% achieving at least 80% scalp hair coverage after 36 weeks on a 4-mg dose, compared to 6.2% with placebo in trial 1.

This study suggests that the floral secretions of Brasiliorchis schunkeana may attract Diptera as potential pollinators, but field observations are needed to confirm this pollination syndrome.

In this retrospective study, researchers found that baricitinib was effective for treating moderate to severe alopecia areata, with response rates in 24 patients comparable to existing real-world data, and no new safety concerns were identified.

This study observed that thymol from Origanum marjoram essential oil significantly promoted hair regrowth and reduced inflammation in cyclophosphamide-induced alopecia in rabbits, with effects that were comparable to or exceeded those of betamethasone, highlighting its potential as a safer treatment alternative.

Abrus precatorius has medicinal benefits but can be toxic.

This study found that Nardostachys jatamansi DC rhizome extracts and specific isolated terpenoids promoted hair growth.

In clinical trials, baricitinib showed significant hair regrowth in patients with severe alopecia areata, especially those with a SALT score of 50 or higher, according to this research. Baricitinib is noted as an alternative to corticosteroids and other JAK inhibitors.

Baricitinib helps regrow hair in teens with severe alopecia areata.

This study found that brassinosteroid enhances kiwifruit root growth by regulating genes involved in auxin signal transduction, highlighting its critical role in root development.

This study observed significant repigmentation in localized stable vitiligo lesions treated with oral baricitinib, with even more improvement when combined with topical tacrolimus, and reported no side effects.

In this study, data from multiple sources found that Baricitinib significantly promoted hair regrowth and improved patient-reported outcomes in those with severe alopecia, with minimal side effects, over a 36-week period.

In this case study, a patient with refractory oral lichen planus experienced marked improvement within one month of daily treatment with baricitinib, contributing to the evidence supporting the use of JAK inhibitors for lichen planus.

In this study, researchers examined Baricitinib's role as a treatment for Alopecia Areata, contrasting it with conventional therapies, and found that while effective, Baricitinib may cause adverse reactions depending on individual patient health histories.

This study found that Bacillus subtilis strain Ydj3 significantly enhanced sweet pepper seed germination, fruit quality, and rhizosphere bacterial composition, including increased yield and vitamin C content, in a commercial greenhouse setting.

This study documented a case where the medication baricitinib effectively promoted hair regrowth in a woman with alopecia areata but also led to an unexpected side effect of hypertrichosis, suggesting a need to further explore the JAK/STAT pathway's role in hair growth dynamics.

Baricitinib helps with early hair regrowth in people with alopecia areata.

This study found that baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata, with similar improvements observed in both clinician-reported and patient-reported measures.

This article describes community efforts to increase awareness and effective utilization of guava plant resources in Pamulang, aiming to improve local economic welfare through better cultivation practices and innovative processing of guava for health benefits.

This study highlights the recent FDA approval of baricitinib as the first on-label treatment for severe alopecia areata, whereas previous treatments were off-label therapies like systemic steroids and immunosuppressants.

This study explored the traditional use of 18 plant-based remedies by the Amarasi people in Indonesia for treating dandruff and hair loss, detailing plant types, parts used, and processing methods, highlighting their potential as anti-dandruff and anti-baldness treatments.

In this study, researchers documented the first instance of alopecia in bats within the Puebla region, specifically affecting two Artibeus jamaicensis and one Choeronycteris mexicana, possibly linked to environmental stress from human activities interfering with their nutrition.

In this phase 3 trial, baricitinib showed effectiveness and safety in both adolescents and adults with severe alopecia areata, with adolescents achieving higher response rates despite more severe baseline conditions, suggesting the advantages of early treatment.

This study found that although soil and forage in Middle Paraíba, Brazil, contained normal to high copper levels, the surrounding bovine populations showed signs of copper deficiency likely due to antagonistic effects from high iron, zinc, and manganese levels.

This cross-meta-analysis examined policosanol biorefining methods in 18 Ibero-American countries, reporting that Cuba, Spain, Brazil, Chile, Mexico, and Portugal show significant advances, but highlighted the need for better coordination between academia and industry for improved yield efficiency.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.